SORT BY Relevancy
Learn firsthand about deployment of ELNs within the biopharmaceutical area - this interview with Ralph Haffner, head of biologic research informatics at Roche, documents the drivers, the planning and selection phase, through to the deployment and integration. He also comments on how the industry is moving forward on creating an IT architecture and offers his views on the potential integration of the iPad to support an ELN system.
ADAM J. FEIN, PH.D.
Drug Channels was created and is written by Adam J. Fein, Ph.D., one of the country’s foremost experts on pharmaceutical economics and channel strategy. The president of Pembroke Consulting, Inc., and CEO of Drug Channels Institute, Dr. Fein consults with clients in the pharmaceutical and healthcare industries. Eleven of the 15 largest biopharmaceutical manufacturers have relied upon Dr. Fein for his experience, analyses, and insights to help them improve profitability and make better strategic decisions.
Dr. Fein excels at unlocking and explaining complex business and economic issues with humor and an accessible, straightforward style, making Drug Channels a popular and authoritative destination for both industry insiders and outsiders.
A conversation with John J. Doyle, Sr. Vice President and Managing Director - Global Market Access at Quintiles, about the need for deeper knowledge of the inherent risks of pharmaceutical products. This need was revealed by The New Health Report 2012, which is based on surveys of biopharmaceutical executives, managed care executives in the U.S., National Health Service executives in the U.K., patients living with chronic disease in both the U.S. and the U.K., and investors who focus on the he
Venture Capital and the State of Healthcare Technology in America: Where are we today and where are we headed?
Cynthia talks to venture capitalist Chuck Newhall, Co-Founder and General Partner of NEA. His investment activities focus on healthcare services, healthcare information services and biopharmaceutical companies; and Dr. Daniel Leung Assistant Professor of Pediatrics at Baylor College of Medicine specializing in Gastroenterology, Hepatology, and Nutrition at Texas Children's Hospital about current healthcare technology trends and ongoing health care needs in the United States.
Can money solve the problem?
Michael Bellomo holds an MBA from the University of California at Irvine, a Juris Doctor in Law from UC San Francisco, and a Black Belt in Lean Six Sigma Manufacturing Techniques from UCSD.
Currently he is a manager at a major biopharmaceutical company, dedicated to the manufacture of plasma-based medicines and therapies.
Michael has written 19 books in various non-fiction fields, including technology, business operations, and 'mass market' science. Michael's books have been published inte
IQPC_NYC speaks with Lyndi Gillespie, Deepa Kumar, and Kimberly Palladino - experts from GlaxoSmithKline on the LSS culture in biopharmaceuticals. The three will be participating in a panel discussion at the 9th Lean Six Sigma for Pharma, Biotech and Medical Device Excellence summit Feb 22-24 in Philadelphia. For more info, visit lsspharm.com.
Rose will discuss temperature controlled packaging in the biopharmaceutical field and also give a glimpse into her segments at IQPC's upcoming Cold Chain Distribution for Pharmaceuticals event that is taking place in Philadelphia, PA from Septemeber 21 - 24.
Join Host Live Chats
- Tracey and Friends (5 chatters)
- TruthRadioNetwork (4 chatters)
- Clay Douglas (4 chatters)
- Joyce BarrieFriends (3 chatters)
- The Road Less Traveled (3 chatters)
- The Wacko Network (3 chatters)
- NEWDradio (1 chatters)
- Red Pill Network (1 chatters)
- Angelically Inspired (1 chatters)
- christianpsychicbrendabradshaw (1 chatters)
- Designing Your Life Today (1 chatters)
- In His Presence MWE (1 chatters)
- Jay King Network (1 chatters)
- Jory Fisher (1 chatters)